Online Only Articles

Relationship between CD33 expression, splicing polymorphism, and in vitro cytotoxicity of gemtuzumab ozogamicin and the CD33/CD3 BiTE® AMG 330

Clinical Research Division, Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center
Hematology/Oncology Fellowship Program
Clinical Research Division, Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center
Clinical Research Division, Fred Hutchinson Cancer Research Center
Hematology/Oncology Fellowship Program;Department of Medicine, Division of Hematology;Department of Epidemiology, University of Washington, Seattle, WA, USA
Vol. 104 No. 2 (2019): February, 2019 https://doi.org/10.3324/haematol.2018.202069